Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Dec;40(4):800–813. doi: 10.1111/j.1476-5381.1970.tb10656.x

Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat

L A Loizou
PMCID: PMC1702913  PMID: 5495178

Abstract

1. A fluorescence histochemical study was undertaken to investigate the ability of systemically administered monoamines to penetrate into the central nervous system of infant rats.

2. It was found that after subcutaneous injections of large doses, L-noradrenaline, L-α-methyl-noradrenaline, DL-α-methyl-dopamine, L-α-methyl-dopa and 5-hydroxytryptamine could cross the blood-brain barrier of newborn to 2 week old rats and be taken up by neurones normally containing monoamine as well as by several neurones which normally contained no monoamine.

3. 5-Hydroxytryptamine containing neurones took up 5-hydroxytryptamine as well as catecholamines and α-methyl-dopa. The pinealocytes, which contain large amounts of 5-hydroxytryptamine, were depleted of their endogenous fluorescence by α-methyl-dopa and showed no selective uptake of catecholamines.

4. The uptake of monoamines was not antagonized by previous reserpine treatment or by inhibition of catecholamine synthesis, and occurred throughout the whole extent of the monoamine-containing neurones (cell body, axon, terminals).

5. The monoamines were also taken up by the endothelial cells and pericytes of capillaries in the central nervous system (CNS) which are thought to constitute the physical barrier to these substances in the adult.

6. The peripheral sympathetic nerves to pial blood vessels, the pineal and pituitary glands also took up the monoamines and α-methyl-dopa; uptake was also noted in cells of the pituitary gland, in epithelial and connective tissue elements of the meninges and choroid plexuses and in the epithelial, connective and muscular tissue of pial blood vessels.

7. It is concluded that the blood-brain barrier to monoamines may not be fully developed in infant rats, at least for high levels of circulating monoamines; the central monoamine-containing neurones possess the `membrane pump' mechanism for uptake of monoamines from the time of birth, even though they are not fully developed morphologically.

Full text

PDF
801

Images in this article

808FIG. 5
on p.808
808FIG. 6
on p.808
804FIG. 1
on p.804
805FIG. 2
on p.805
806FIG. 3
on p.806
807FIG. 4
on p.807
809FIG. 7
on p.809
810FIG. 8
on p.810

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD J., WEIL-MALHERBE H., TOMCHICK R. The physiological disposition of H3-epinephrine and its metabolite metanephrine. J Pharmacol Exp Ther. 1959 Dec;127:251–256. [PubMed] [Google Scholar]
  2. BERTLER A., FALCK B., ROSENGREN E. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES. Acta Pharmacol Toxicol (Copenh) 1963;20:317–321. doi: 10.1111/j.1600-0773.1964.tb01752.x. [DOI] [PubMed] [Google Scholar]
  3. Bertler A., Falck B., Owman C., Rosengrenn E. The localization of monoaminergic blood-brain barrier mechanisms. Pharmacol Rev. 1966 Mar;18(1):369–385. [PubMed] [Google Scholar]
  4. Bulat M., Supek Z. Mechanism of 5-hydroxytryptamine penetration through the cerebrospinal fluid-brain barrier. Nature. 1968 Jul 6;219(5149):72–73. doi: 10.1038/219072a0. [DOI] [PubMed] [Google Scholar]
  5. Bulat M., Supek Z. Passage of 5-hydroxytryptamine through the blood-brain barrier, its metabolism in the brain and elimination of 5-hydroxyindoleacetic acid from the brain tissue. J Neurochem. 1968 May;15(5):383–389. doi: 10.1111/j.1471-4159.1968.tb11625.x. [DOI] [PubMed] [Google Scholar]
  6. FUXE K., HILLARP N. A. UPTAKE OF L-DOPA AND NORADRENALINE BY CENTRAL CATECHOLAMINE NEURONS. Life Sci. 1964 Dec;3:1403–1406. doi: 10.1016/0024-3205(64)90081-5. [DOI] [PubMed] [Google Scholar]
  7. Fuxe K., Ungerstedt U. Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections. Histochemie. 1968;13(1):16–28. doi: 10.1007/BF00303872. [DOI] [PubMed] [Google Scholar]
  8. Fuxe K., Ungerstedt U. Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. Eur J Pharmacol. 1968 Sep;4(2):135–144. doi: 10.1016/0014-2999(68)90169-6. [DOI] [PubMed] [Google Scholar]
  9. GLOWINSKI J., AXELROD J., KOPIN I. J., WURTMAN R. J. PHYSIOLOGICAL DISPOSITION OF H3-NOREPINEPHRINE IN THE DEVELOPING RAT. J Pharmacol Exp Ther. 1964 Oct;146:48–53. [PubMed] [Google Scholar]
  10. GLOWINSKI J., KOPIN I. J., AXELROD J. METABOLISM OF (H3)NOREPINEPHRINE IN THE RAT BRAIN. J Neurochem. 1965 Jan;12:25–30. doi: 10.1111/j.1471-4159.1965.tb10247.x. [DOI] [PubMed] [Google Scholar]
  11. Hamberger A., Hamberger B. Uptake of catecholamines and penetration of trypan blue after blood-brain barrier lesions. A histochemical study. Z Zellforsch Mikrosk Anat. 1966;70(3):386–392. doi: 10.1007/BF00336504. [DOI] [PubMed] [Google Scholar]
  12. Hamberger B. Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. A histochemical study. Acta Physiol Scand Suppl. 1967;295:1–56. [PubMed] [Google Scholar]
  13. Henning M. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats. Acta Pharmacol Toxicol (Copenh) 1969;27(2):135–148. doi: 10.1111/j.1600-0773.1969.tb00501.x. [DOI] [PubMed] [Google Scholar]
  14. Håkanson R., Lombard des Gouttes M. N., Owman C. Activities of tryptophan hydroxylase, dopa decarboxylase, and monoamine oxidase as correlated with the appearance of monoamines in developing rat pineal gland. Life Sci. 1967 Dec 15;6(24):2577–2585. doi: 10.1016/0024-3205(67)90107-5. [DOI] [PubMed] [Google Scholar]
  15. Lichtensteiger W., Langemann H. Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons. J Pharmacol Exp Ther. 1966 Mar;151(3):400–408. [PubMed] [Google Scholar]
  16. Lichtensteiger W., Mutzner U., Langemann H. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines. J Neurochem. 1967 May;14(5):489–497. doi: 10.1111/j.1471-4159.1967.tb09548.x. [DOI] [PubMed] [Google Scholar]
  17. Lichtensteiger W. Uptake of norepinephrine in periglomerular cells of the olfactory bulb of the mouse. Nature. 1966 May 28;210(5039):955–956. doi: 10.1038/210955a0. [DOI] [PubMed] [Google Scholar]
  18. Loizou L. A. The development of monoamine-containing neurones in the brain of the albino rat. J Anat. 1969 May;104(Pt 3):588–588. [PubMed] [Google Scholar]
  19. Lundborg P. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues. Acta Physiol Scand Suppl. 1967;302:1–34. [PubMed] [Google Scholar]
  20. Owman C., Rosengren E. Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism. J Neurochem. 1967 May;14(5):547–550. doi: 10.1111/j.1471-4159.1967.tb09553.x. [DOI] [PubMed] [Google Scholar]
  21. SMITH S. E. The pharmacological actions of 3,4-dihydroxyphenyl-alpha-methylalanine (alpha-methyldopa), an inhibitor of 5-hydroxytryptophan decarboxylase. Br J Pharmacol Chemother. 1960 Jun;15:319–327. doi: 10.1111/j.1476-5381.1960.tb01251.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Uretsky N. J., Seiden L. S. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response. J Pharmacol Exp Ther. 1969 Jul;168(1):153–162. [PubMed] [Google Scholar]
  23. WEIL-MALHERBE H., WHITBY L. G., AXELROD J. The uptake of circulating [3H]norepinephrine by the pituitary gland and various areas of the brain. J Neurochem. 1961 Oct;8:55–64. doi: 10.1111/j.1471-4159.1961.tb13526.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES